27.07.2011 • NewsMerckQ2 2011sales and profits

Merck KGaA Slips To Loss In Q2; Trims FY11 Profit Forecast

German drug manufacturer Merck KGaA reported Wednesday that its second-quarter net loss attributable to the company was €85.9 million or €0.40 per share, compared to prior year's profit of €183.4 million or €0.84 per share.

Core earnings per share, which excluded certain one-time items, declined 39.7% to €0.94 from €1.56 last year.

Total revenues increased 15.7% to €2.56 billion from €2.21 billion a year ago.

For the quarter, core operating result declined from last year, while underlying core operating result grew to €548 million from €501 million in 2010.

Looking ahead for fiscal 2011, the company now projects total revenues will increase to between €10 billion and €10.4 billion. The group operating result for 2011 is expected to amount to about €1 billion, which is below the guidance given in April primarily due to the many one-time adjustments.
The company's previous forecast for total revenues was a growth of 10 -15%.

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.